Home NDC 25021-179 Daptomycin
Product NDC 25021-179
11-digit product format 250210179
Labeler code 25021
Product ID 25021-179_4245fbb1-e161-4c27-93b6-6afb59618099
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Daptomycin
Dosage form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route INTRAVENOUS
Labeler Sagent Pharmaceuticals
Application NDA208385
Marketing category NDA
Marketing start 2018-01-15
Substance DAPTOMYCIN
Active strength 350 mg/7mL
Pharmacologic classes Lipopeptide Antibacterial [EPC], Lipopeptides [CS]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N208385-001 DAPTOMYCIN DAPTOMYCIN 350MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2017-09-12
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code N208385-001 AP
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 42 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 N208385-001 DAPTOMYCIN 350MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2017-09-12 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N208385-001 DAPTOMYCIN 350MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2017-09-12 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N208385-001 DAPTOMYCIN 350MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2017-09-12 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N208385-001 DAPTOMYCIN 350MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2017-09-12 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N208385-001 DAPTOMYCIN 350MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2017-09-12 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N208385-001 DAPTOMYCIN 350MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2017-09-12 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N208385-001 DAPTOMYCIN 350MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2017-09-12 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N208385-001 DAPTOMYCIN 350MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2017-09-12 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N208385-001 DAPTOMYCIN 350MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2017-09-12 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N208385-001 DAPTOMYCIN 350MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2017-09-12 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N208385-001 DAPTOMYCIN 350MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2017-09-12 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N208385-001 DAPTOMYCIN 350MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2017-09-12 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N208385-001 DAPTOMYCIN 350MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2017-09-12 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N208385-001 DAPTOMYCIN 350MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2017-09-12 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N208385-001 DAPTOMYCIN 350MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2017-09-12 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N208385-001 DAPTOMYCIN 350MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2017-09-12 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N208385-001 DAPTOMYCIN 350MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2017-09-12 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N208385-001 DAPTOMYCIN 350MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2017-09-12 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N208385-001 DAPTOMYCIN 350MG/VIAL POWDER / IV (INFUSION) AP RLD, RS 2017-09-12 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N208385-001 DAPTOMYCIN 350MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2017-09-12 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N208385-001 DAPTOMYCIN 350MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2017-09-12 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N208385-001 DAPTOMYCIN 350MG/VIAL POWDER / IV (INFUSION) AP RLD, RS 2017-09-12 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N208385-001 DAPTOMYCIN 350MG/VIAL POWDER / IV (INFUSION) AP RLD, RS 2017-09-12 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N208385-001 DAPTOMYCIN 350MG/VIAL POWDER / IV (INFUSION) AP RLD, RS 2017-09-12 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N208385-001 DAPTOMYCIN 350MG/VIAL POWDER / IV (INFUSION) AP RLD, RS 2017-09-12 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N208385-001 DAPTOMYCIN 350MG/VIAL POWDER / IV (INFUSION) AP RLD, RS 2017-09-12 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N208385-001 DAPTOMYCIN 350MG/VIAL POWDER / IV (INFUSION) AP RLD, RS 2017-09-12 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N208385-001 DAPTOMYCIN 350MG/VIAL POWDER / IV (INFUSION) RLD, RS 2017-09-12 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N208385-001 DAPTOMYCIN 350MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2017-09-12 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N208385-001 DAPTOMYCIN 350MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2017-09-12 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N208385-001 DAPTOMYCIN 350MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2017-09-12 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N208385-001 DAPTOMYCIN 350MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2017-09-12 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N208385-001 DAPTOMYCIN 350MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2017-09-12 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N208385-001 DAPTOMYCIN 350MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2017-09-12 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N208385-001 DAPTOMYCIN 350MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2017-09-12 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N208385-001 DAPTOMYCIN 350MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2017-09-12 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N208385-001 DAPTOMYCIN 350MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2017-09-12 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N208385-001 DAPTOMYCIN 350MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2017-09-12 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N208385-001 DAPTOMYCIN 350MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2017-09-12 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N208385-001 DAPTOMYCIN 350MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2017-09-12 e64feba35796…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 41 observed states.
Additional Listing Data#
Finished product Yes
Brand name base Daptomycin
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength DAPTOMYCIN 350 mg/7mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination NWQ5N31VKK Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 1996246 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 25021-179-15 Daptomycin 7 mL in 1 VIAL INJECTION, POWDER, LYOPHILIZED, 7 21 25021-179-15 Daptomycin 1 in 1 CARTON INJECTION, POWDER, LYOPHILIZED, 1 21 25021-179-16 Daptomycin 10 in 1 CARTON INJECTION, POWDER, LYOPHILIZED, 10 21 25021-179-16 Daptomycin 7 mL in 1 VIAL INJECTION, POWDER, LYOPHILIZED, 7 21 25021-179-66 Daptomycin 7 mL in 1 VIAL INJECTION, POWDER, LYOPHILIZED, 7 3 25021-179-66 Daptomycin 1 in 1 CARTON INJECTION, POWDER, LYOPHILIZED, 1 3 25021-179-67 Daptomycin 10 in 1 CARTON INJECTION, POWDER, LYOPHILIZED, 10 3 25021-179-67 Daptomycin 7 mL in 1 VIAL INJECTION, POWDER, LYOPHILIZED, 7 3
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 25021-179 DAPTOMYCIN INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [SAGENT PHARMACEUTICALS] 21 Current NDC, Legacy NDC, 4 package rows 20241024_548f3559-0531-4c95-9e1d-81f81a3801f1.zip 25021-179 DAPTOMYCIN INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [SAGENT PHARMACEUTICALS] 3 Current NDC, Legacy NDC, 4 package rows 20230629_4a0ad110-e55e-4d3b-84f8-dd0b924fe2f6.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 25021-179-15 25021017915 1 VIAL in 1 CARTON (25021-179-15) / 7 mL in 1 VIAL 1 vial 2018-01-15 0000-00-00 No No Current 25021-179-16 25021017916 10 VIAL in 1 CARTON (25021-179-16) / 7 mL in 1 VIAL 10 vial 2018-01-15 0000-00-00 No No Current 25021-179-66 25021017966 1 VIAL in 1 CARTON (25021-179-66) / 7 mL in 1 VIAL 1 vial 2020-02-01 0000-00-00 No No Current 25021-179-67 25021017967 10 VIAL in 1 CARTON (25021-179-67) / 7 mL in 1 VIAL 10 vial 2020-02-01 0000-00-00 No No Current